By THE ASSOCIATED PRESS
The Senate’s Special Committee on Aging requested documents and information from Turing, Valeant and two other drug makers already under scrutiny for recent price increases.
Published: November 5, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1QegfnM
from WordPress http://ift.tt/1QehYtj
via Hadi Aboukhater
No comments:
Post a Comment